• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

MELA Sciences

NASDAQ:MELA

$2.69 -$0.08 (-2.89%)

REAL-TIME: Last trade at

Boston Scientific and MELA Sciences Look to Benefit From Plan to Speed Up FDA Reviews

MELA Sciences initiated with an Outperform at Cowen

MELA Sciences reports Q1 EPS (19c), consensus (21c)

MELA Sciences to host analyst meeting

MELA Sciences Named 2012 Bronze Edison Award Winner

MELA Sciences to Present at the 37th Annual Deutsche Bank Health Care Conference

MELA Sciences to Host Investor Meeting May 7, 2012 in New York

MELA Sciences to Release First Quarter Financial Results and Host Conference Call on Thursday, May 3, 2012

MELA Sciences falls 8.9%

Needham to host a conference

MELA Sciences to Present at Upcoming Investor Conference

MELA Sciences, Quintiles in agreement for MelaFind commercial support services

MELA Sciences Announces Agreement With Quintiles for Commercial Support Services for MelaFind(R) in Germany

MELA Sciences Announces Commercial Launch of MelaFind(R)

MELA Sciences to Present at Upcoming Investor Conferences

MELA Sciences says study shows MelaFind improves melanoma detection

MelaFind(R) Results Improve Detection of Melanoma, Study Shows

MELA Sciences to Present at Upcoming Investor Conferences

MELA Sciences in expanded manufacturing agreement with Askion

MELA Sciences Expands Manufacturing Contract

MELA Sciences to Present at 14th Annual Needham Growth Conference

MELA Sciences 5M share Spot Secondary priced at $3.25

MELA Sciences Announces Pricing of Underwritten Public Offering of Common Stock

MELA Sciences Announces Additions to Board of Directors

MELA Sciences to Present at Piper Jaffray 23rd Annual Healthcare Conference

Options Market Picks: 9 Highly Liquid Stocks With Bullish Options Sentiment

This Just In: More Upgrades and Downgrades

MELA Sciences initiated with an Overweight at Stephens

MELA Sciences to Present at Upcoming Investor Conferences

ElectroOptical Sciences Inc Reports Operating Results (10-Q)

MELA Sciences price target raised to $20 from $14 at Needham

MELA Sciences announces FDA approval for MelaFind

MELA Sciences Announces FDA Approval for MelaFind(R)

Analyst View, Impact of Global Events - Research Report on MELA Sciences, Inc. and SIGA Technologies, Inc.

Whoa! What Just Happened to My Stock?

MELA Sciences rises 16.8%

Whoa! My Stock Just Crushed the Market!

7 Stocks Rising on Unusual Volume

MELA Sciences Inc. (MELA) Set A 10-Month High On FDA News

MELA Sciences target range raised to $13-$15 from $11 at Leerink

See More Articles...